Financial & competing interests disclosure
Michael Kleerekoper is Chief Medical Officer of MicroMRI Inc., a medical device company involved in the assessment of bone microarchitecture using high-resolution MRI. Kleerekoper is a member of the Board of Trustees of the National Osteoporosis Foundation. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.